LifeMD 报告第二季度收益好于预期，但其股价仍跌至 4.27 美元。 LifeMD reported better-than-expected Q2 earnings, but its stock still fell to $4.27.

LifeMD是一家远程保健公司,报告其Q2收入高于预期,EPS为0.02美元,殴打分析师的估计为0.04美元。 LifeMD, a telehealth company, reported better-than-expected Q2 earnings, with EPS at ($0.02), beating analysts' estimates of ($0.04). 尽管如此,其库存在星期一却下降了0.40美元至4.27美元。 Despite this, its stock fell $0.40 to $4.27 on Monday. LifeMD经营的市场上限为1.8494亿美元,并通过RexMD、ShapiroMD、NavaMD和Cleared等品牌提供服务。 LifeMD operates a market cap of $184.94 million and offers services through brands like RexMD, ShapiroMD, NavaMD, and Cleared. 该公司的“机动买家”评级为11.14美元,目标价格为11.14美元。 The company has a "Moderate Buy" rating with a target price of $11.14. 在2025年,LifeMD预计合并收入在2.65亿至2.75亿美元之间,调整后的EBITDA为3000万至3200万美元. In 2025, LifeMD forecast consolidated revenue between $265 million to $275 million and adjusted EBITDA of $30 million to $32 million.